Histologix is attending Applications of in situ hybridisation and spatial profiling methods in research and disease.

Applications of in situ hybridisation and spatial profiling methods in research and disease.

We are excited to announce that HistologiX will be attending the upcoming conference on Applications of in situ hybridisation and spatial profiling methods in research and disease. This event will take place on May 16-17, 2023, at the Cancer Research UK (CRUK) Cambridge Institute.

The conference aims to bring together leading experts in the field of molecular pathology and spatial genomics to discuss recent advances and applications of in situ hybridisation and spatial profiling methods in research and disease diagnosis. Participants will have the opportunity to learn about a variety of topics, including the principles and applications of in situ hybridisation, spatial transcriptomics, imaging mass cytometry, and other spatial profiling methods, as well as their clinical and translational applications.

In addition to the informative sessions, participants will have the opportunity to present their own research and network with other professionals in the field. We believe this will be a great opportunity for attendees to expand their knowledge and stay up-to-date with the latest developments in this exciting field.

We look forward to seeing you at the event and invite you to check back with us for updates on our participation in this exciting conference.

Date/Time

16th-17th May 2023  

Event type

Conference

Attendees

Michaela Downie, Agata Stryjewska

Attendees

Michaela Downie

Business Development Manager

Michaela is our Business Development Manager, responsible for strengthening relationships with existing clients and identifying new areas to grow the business. She has 20+ years of experience working globally with Biotech and Pharma Clients in Key Account and Business Development positions across the Life Sciences CRO sector.

Michaela began her scientific career at the University of Cambridge as a PostDoc in Dermatology, researching inflammatory skin diseases employing a variety of molecular and histology techniques including IHC and ISH. Michaela holds a PhD in Clinical Biochemistry from the University of Cambridge and a Diplom in Biology from the University of Cologne.

Agata Stryjewska

Senior Scientist – Immunofluorescence

Agata is our immunofluorescence specialist with expertise in both fluorescence and chromogenic antibody validation methods. She is currently developing bespoke multiplex immunofluorescence assays for our clients’ projects. Agata also manages our Ultivue projects, offering multiplex immunofluorescence (mIF) solutions and RNAScope projects for the detection of RNA in tissues.

Agata has a Masters degree in Biotechnology from the University of Science and Technology, Wroclaw, and a PhD from the University of Leuven. She has extensive collaborative postdoctoral research experience in neuroscience, stem cells, developmental biology and immunology.

Facebook
Twitter
LinkedIn

Find out more about our services

Stay up to date with HistologiX